Cover Image

Multiple Lineage Switches in a Pediatric Case With a KMT2A::AFF1‐Positive Acute Lymphoblastic Leukemia: How Cell Plasticity Induces Immunotherapy Failure

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Luca Lo Nigro, Marta Arrabito, Emanuela Cannata, Manuela La Rosa, Valeria Iachelli, Paola Bonaccorso
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Pediatric Blood & Cancer
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Visceral Fat and Body Fat as Risk Factors for Methotrexate Toxicity in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
by: Alda Daniela García‐Guzmán, et al.
Published: (2025)

Secondary T‐Lymphoblastic Lymphoma With KMT2A::MAML2 Rearrangement Following Myeloid Sarcoma and RUNX1::RUNX1T1‐Positive Acute Myeloid Leukemia
by: Ting Li, et al.
Published: (2026)

Reduced‐Intensity Chemotherapy With Immunotherapy for Children With Down Syndrome and B‐Cell Acute Lymphoblastic Leukemia
by: Ashley C. Holland, et al.
Published: (2025)

Heterogeneity in the Global Practice of Central Nervous System Staging in Pediatric Acute Lymphoblastic Leukemia
by: Laura Almási, et al.
Published: (2026)

Blinatumomab Utilization in Pediatric B‐Cell Acute Lymphoblastic Leukemia: Experience From the Mountain West
by: Angela Parra del Riego, et al.
Published: (2026)

Use of Oral Metformin Therapy for Therapy‐Induced Hyperglycemia in Pediatric Patients With Acute Lymphoblastic Leukemia
by: Ankita Chakraborty, et al.
Published: (2026)

Attitudes Toward COVID‐19 Vaccination Among Pediatric Acute Lymphoblastic Leukemia Patients and Their Caregivers
by: Janna R. Shapiro, et al.
Published: (2025)

Cytarabine‐Related Neurotoxicity in an Infant With Acute Lymphoblastic Leukemia
by: Ashley C. Holland, et al.
Published: (2025)

Pediatric Acute B‐Lymphoblastic Leukemia Presenting as Hypereosinophilia With Lung Involvement and Elevated Immunoglobulin E Levels
by: Aida Zeckanovic, et al.
Published: (2024)

Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
by: Andrew E. Place, et al.
Published: (2025)

Impact of Invasive Fungal Diseases on Treatment Outcomes in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: Insights From a Single‐Center Study
by: Amrutha Narayana Murthy, et al.
Published: (2025)

BCG Infection Following Therapy of Infant Acute Lymphoblastic Leukemia
by: Mikhail Lemeshev, et al.
Published: (2026)

Monosomy 10 Mosaicism as an Incidental Finding in Acute Lymphoblastic Leukemia
by: Dany Assaf Curi, et al.
Published: (2025)

Blinatumomab‐Associated Psychosis in an Adolescent With B‐Cell Acute Lymphoblastic Leukemia
by: Eesha A. Zaheer, et al.
Published: (2026)

Bridging the Gap in Pediatric Relapsed Acute Lymphoblastic Leukemia Treatment: Insights and Outcomes From the ALL‐IC REL 2016 Guidelines
by: Marko Kavcic, et al.
Published: (2025)

Management of Philadelphia Chromosome‐Positive B‐Lymphoblastic Leukemia Diagnosed in an Infant
by: Jessica A. O. Zimmerman, et al.
Published: (2025)

Successful Management of Lineage Switch Infant Leukemia With Revumenib and Hematopoietic Cell Transplantation
by: Rachel E. Granberg, et al.
Published: (2026)

Disseminated Infection Following the Administration of the Varicella Vaccine in a Child with Acute Lymphoblastic Leukemia
by: Ryo Hanaki, et al.
Published: (2025)

Sedation with Oral Dexmedetomidine Premedication in Pediatric Patients With Acute Lymphoblastic Leukemia Undergoing Blood Sampling: A Randomized, Double‐Blind Clinical Trial
by: Farshad Khoddami, et al.
Published: (2026)

Ethnic Differences in the Association Between SOD2 rs4880 and Hepatotoxicity in Pediatric Acute Lymphoblastic Leukemia: A Report From the REDIAL Consortium
by: Emily J. Mason, et al.
Published: (2026)

Pediatric B‐Cell Acute Lymphoblastic Leukemia With FUS::FLI1 Fusion in an Infant With Measurable Residual Disease: Sustained Molecular Remission Achieved With Blinatumomab
by: Qiang Yao, et al.
Published: (2025)

Venetoclax Plus Daratumumab Bridging Allo‐HSCT in Early T‐Cell Precursor Acute Lymphoblastic Leukemia
by: Fanqiao Meng, et al.
Published: (2025)

Characterizing Parental Concerns About Lasting Impacts of Treatment in Children With B‐Acute Lymphoblastic Leukemia
by: Kellee N. Parker, et al.
Published: (2026)

Caregiving for Children With Acute Lymphoblastic Leukemia Receiving Home‐Based Blinatumomab: Caregiver Experiences and Recommendations
by: Sue Zupanec, et al.
Published: (2025)

Late Onset Blinatumomab‐Related Neurotoxicity in a Child With B‐Cell Acute Lymphoblastic Leukemia
by: Krunal Shah, et al.
Published: (2025)

A Novel TAL2::TCRB Fusion With PI3K/AKT Pathway Mutations in Pediatric T‐Cell Acute Lymphoblastic Leukemia: Diagnostic and Therapeutic Implications
by: Qiang Yao, et al.
Published: (2025)

Serological Benefit of SARS‐CoV‐2 Vaccination Relative to Infection in Children With Acute Lymphoblastic Leukemia
by: Janna R. Shapiro, et al.
Published: (2026)

A Comparative Analysis of Clinical Utility of Cytogenetics and Copy‐Number–Integrated Risk Stratification Scores in a Prospective Cohort of Pediatric B‐Cell Acute Lymphoblastic Leukemia
by: Ajmeera A. Azeez, et al.
Published: (2025)

Sustained Remission in a Pediatric B‐Cell Acute Lymphoblastic Leukemia With Rare PAX5::KIAA1549L Fusion and Complex Karyotype Following Blinatumomab Consolidation
by: Xiaoyong Chen, et al.
Published: (2025)

A PRSZT Registry Analysis of Prognostic Factors Influencing Survival and Relapse Rates After Second Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia
by: Ava Momm, et al.
Published: (2026)

CIC‐Rearrangements in Pediatric Acute Erythroid Leukemia/Erythroblastic Sarcoma
by: Alexandra L. Chang‐Graham, et al.
Published: (2025)

A Retrospective Study to Identify Demographic and Clinical Risk Factors for the Development of Methotrexate‐Associated Neurotoxicity in Children and Young Adults With Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
by: Cassandra Grello, et al.
Published: (2025)

Results of a Randomized Augmented Intensification Phase in Acute Lymphoblastic Leukemia in Children in Argentina: GATLA 2010 ALL IC Trial
by: Maria C. Riccheri, et al.
Published: (2025)

Quality of Life Priorities of Childhood Acute Lymphoblastic Leukemia Survivors Enrolled in EORTC Studies, and a Comparison of Instruments
by: Jammbe Musoro, et al.
Published: (2024)

Prolonged Hypogammaglobulinemia in a Child With Down Syndrome After Treatment of Acute Lymphoblastic Leukemia With Immunochemotherapy Including Blinatumomab
by: Reena Pabari, et al.
Published: (2025)

Comment on: A Comparative Analysis of Clinical Utility of Cytogenetics and Copy‐Number–Integrated Risk Stratification Scores in a Prospective Cohort of Pediatric B‐Cell Acute Lymphoblastic Leukemia
by: Donát Alpár, et al.
Published: (2025)

First‐Line Postremission Blinatumomab as Successful Toxicity‐Sparing Strategy in a Boy with Cystic Fibrosis and Acute Lymphoblastic Leukemia
by: Nicolò Peccatori, et al.
Published: (2025)

Central Adiposity and Visceral Fat in Long‐Term Survivors of Acute Lymphoblastic Leukemia in Childhood and Adolescence: Exploration of an Underappreciated Risk
by: Louise Guolla, et al.
Published: (2025)

Successful Caribbean Cooperation in Childhood Cancer Care: The Martinique—St. Lucia–Dominica Experience in the Management of Acute Lymphoblastic Leukemia
by: Julie Mascle, et al.
Published: (2025)

Baseline Characteristics of Parents Enrolled in Children's Oncology Group Study ACCL20N1CD: Financial Toxicity During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States
by: Sheila Judge Santacroce, et al.
Published: (2025)